Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
letter
. 2012 Mar;56(3):1668–1669. doi: 10.1128/AAC.05942-11

Expansion of Clonal Complex 258 KPC-2-Producing Klebsiella pneumoniae in Latin American Hospitals: Report of the SENTRY Antimicrobial Surveillance Program

Mariana Castanheira 1,, Andrew J Costello 1, Lalitagauri M Deshpande 1, Ronald N Jones 1
PMCID: PMC3294890  PMID: 22337899

LETTER

We read with interest the article by Andrade et al. (1) describing the presence of the KPC-producing Klebsiella pneumoniae clonal complex 258 (CC258), including sequence type 258 (ST258), ST11, and ST437, in Brazilian hospitals. CC258 K. pneumoniae strains have been described in several countries and have been associated with the dissemination of blaKPC-2 and blaKPC-3. As part of the SENTRY Antimicrobial Surveillance Program, we monitored the prevalence of carbapenem resistance among 1,684 Enterobacteriaceae isolates collected during 2010 in five Latin American countries: Argentina (two hospitals), Brazil (six hospitals), Chile (two hospitals), Colombia (one hospital), and Mexico (four hospitals), and we have recently noticed a dramatic increase in carbapenem resistance in these institutions (3). The findings published by Andrade et al. (1) led us to screen isolates for the presence of carbapenemases (3) and evaluate the genetic relationships among KPC-producing K. pneumoniae isolates from Latin America and the presence of CC258.

Among 70 (4.2% overall) carbapenem-nonsusceptible Enterobacteriaceae isolates (MIC, ≥2 μg/ml for imipenem or meropenem) (4) submitted by Latin American hospitals during 2010, blaKPC-2 was detected in 56 strains (3.3% overall; 47 K. pneumoniae, 3 Escherichia coli, 4 Enterobacter cloacae, and 2 Citrobacter freundii strains), and all were recovered from patients in three countries: Argentina (15 strains from two hospitals), Brazil (44 strains from three hospitals), and Colombia (5 strains from one hospital) (Table 1). The remaining carbapenem-resistant strains were either negative for the production of carbapenemases (12 strains) or produced VIM-23 (two strains from Durango, Mexico) (2). All 47 KPC-2-producing K. pneumoniae isolates were typed by pulsed-field gel electrophoresis (PFGE), as previously described (6), and selected strains were evaluated by multilocus sequence type (MLST) according to the instructions on the website http://www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.html.

Table 1.

KPC-2-producing Enterobacteriaceae from Latin American hospitals collected during the SENTRY Antimicrobial Surveillance Program in 2010

Country and city KPC-2-producing species (no. of strains) PFGE pattern (no. of strains) MLSTa
Argentina
    Buenos Aires—hospital 1 K. pneumoniae (10) 39A (1) NTb
39B (1) ST738
39C (1) NT
39D (2) ST11
39E (1) ST11
39F (2) NT
39G (2) NT
E. cloacae (1) NT NT
    Buenos Aires—hospital 2 K. pneumoniae (1) 40A (1) ST258
Brazil
    Brasília K. pneumoniae (21) 101A (1) NT
101B (6) ST11
101C (4; 3 subtypes) ST11
101D (4; 2 subtypes) ST11
101E (3; 2 subtypes) ST340
101F (1) ST11
101G (1) ST11
101H (1) ST37
E. coli (1) NT NT
    São Luís K. pneumoniae (2) 327A ST737
E. cloacae (1) NT NT
    São Paulo K. pneumoniae (12) 48A (1) NT
48B (11) ST437
E. coli (2) NT NT
Colombia
    Medellin K. pneumoniae (1) 44A (1) ST327
C. freundii (2) NT NT
E. cloacae (2) NT NT
a

Underlined types are those not related to CC258 (>2 different allelic variants).

b

NT, not tested.

Molecular typing showed that among 10 KPC-2-producing K. pneumoniae strains from one Argentinean hospital, seven different PFGE patterns were detected, and 2 strains tested belonged to ST11, part of CC258 (Table 1). Similar genetic diversity was observed in Brasília, Brazil, where eight different patterns were noted among 21 strains, and among seven strains selected for MLST, six grouped within CC258 (ST11 [5 strains] and ST340) (1) (Table 1). Among 12 isolates collected in São Paulo, Brazil, the strains clustered in two patterns, one having the vast majority of the strains (11/12) and belonging to ST437, also part of CC258. Other hospitals had smaller numbers of strains and, as a consequence, less genetic diversity. CC258-related STs were only detected in one of the three remaining hospitals (hospital 2 in Buenos Aires, Argentina [ST258]) (Table 1). Two new ST types unrelated to CC258, ST737 and ST738, were assigned to strains from São Luís, Brazil, and Buenos Aires, Argentina, respectively.

In summary, STs belonging to CC258 were detected in hospitals from Argentina and Brasília and São Paulo, Brazil, including a total of 34 of 47 KPC-2-producing K. pneumoniae strains collected in Latin American hospitals. In this report, we document and confirm the findings of Andrade et al. (1) and others (5) of the expansion of CC258 strains carrying blaKPC-2 for Latin American hospitals. We further detected CC258 KPC-2-producers among the majority of the carbapenem-resistant strains from monitored Latin American hospitals. The presence of other resistance mechanisms and other strain types was also observed.

ACKNOWLEDGMENTS

We thank the Latin American participants of the SENTRY Antimicrobial Surveillance Program: J. Smayevsky, Buenos Aires, Argentina; J. Casellas, Buenos Aires, Argentina; V. Prado, Santiago, Chile; P. Garcia, Santiago, Chile; J. Robledo, Medellin, Colombia; C. M. Zoccoli, Florianopolis, Brazil; A. C. Gales, São Paulo, Brazil; A. L. Barth, Porto Alegre, Brazil; J. Ribeiro, Brasília, Brazil, R. Morfin-Otero, Guadalajara, Mexico; J. C. Tinoco, Durango, Mexico; P. Del Peloso, Rio de Janeiro, Brazil; E. Garza-González, Monterrey, Mexico; P. Cornejo, Tlalpan, Mexico; and R. Cipriano, São Luís, Brazil.

REFERENCES

  • 1. Andrade LN, et al. 2011. Dissemination of blaKPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil. Antimicrob. Agents Chemother. 55:3579–3583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Castanheira M, et al. 2011. Comment on role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-{beta}-lactamases. J. Antimicrob. Chemother. 66:684–685 [DOI] [PubMed] [Google Scholar]
  • 3. Castanheira M, Mendes RE, Woosley LN, Jones RN. 2011. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY Antimicrobial Surveillance Programme (2007–09). J. Antimicrob. Chemother. 66:1409–1411 [DOI] [PubMed] [Google Scholar]
  • 4. Clinical and Laboratory Standards Institute 2011. M100-S21 Performance standards for antimicrobial susceptibility testing: 21st informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA [Google Scholar]
  • 5. Gomez SA, et al. 2011. Clonal dissemination of Klebsiella pneumoniae ST258 harbouring KPC-2 in Argentina. Clin. Microbiol. Infect. 17:1520–1524 [DOI] [PubMed] [Google Scholar]
  • 6. Tenover FC, et al. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233–2239 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES